The Procedures for Resolving Objections to the Conclusion of Drug Registration Review (Trial) was issued on Sep.01, 2020. It aims to promote the implementation of the Drug Registration Administration Measures, which includes relevant policies, regulations, and measures.
- Local Title:药品注册审评结论异议解决程序(试行)
- Country/Region:Chinese Mainland
- Competent Authority: National Medical Products Administration (NMPA)
- Type:Regulation
- Status:In force
- Release Date:2020-09-01
- Implementation Date:2020-09-01